---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-027499"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2026-06-05T20:30:44+00:00"
generated_at: "2026-06-05T20:40:21.059424+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Indaptus Therapeutics announces resignation of two directors and COO; COO to serve as consultant

## Summary
- David E. Lazar and Avraham Ben-Tzvi resigned from all director positions and committees effective June 5, 2026.
- Walt A. Linscott resigned as COO effective June 1, 2026, and will serve as consultant under a consulting agreement.
- Resignations were not due to any disagreement with the company's operations, policies, or practices.
- No replacements for directors or COO were announced; CEO Junyi Dai remains in place.

## SEC filing metadata
- accession: 0001493152-26-027499
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2026-06-05T20:30:44+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000149315226027499/0001493152-26-027499-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000149315226027499/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-027499
- JSON: https://secwatch.observer/filing/0001493152-26-027499.json
- Plain text: https://secwatch.observer/filing/0001493152-26-027499.txt

## Key facts
- Executive change
  David E. Lazar resigned as Director at Indaptus Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: Effective as of June 5, 2026, Mr. David E. Lazar and Mr. Avraham Ben-Tzvi resigned from all directorship positions, including from all committees served, on the Board of Directors (the “ Board ”) of Indaptus Therapeutics, Inc. (the “ Company ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1857044/000149315226027499/0001493152-26-027499-index.htm
- Executive change
  Walt A. Linscott resigned as Chief Operating Officer at Indaptus Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Operating Officer
  source text: Effective as of June 1, 2026, Mr. Walt A. Linscott, Esq. resigned as the Chief Operating Officer of the Company, and, pursuant to a consulting agreement with the Company dated June 1, 2026, will serve as a consultant for the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1857044/000149315226027499/0001493152-26-027499-index.htm
- Executive change
  Avraham Ben-Tzvi resigned as Director at Indaptus Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: Effective as of June 5, 2026, Mr. David E. Lazar and Mr. Avraham Ben-Tzvi resigned from all directorship positions, including from all committees served, on the Board of Directors (the “ Board ”) of Indaptus Therapeutics, Inc. (the “ Company ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1857044/000149315226027499/0001493152-26-027499-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.